Microcirculatory Hemodynamics and Endothelial Dysfunction in Systemic Lupus Erythematosus

Objective—Impaired flow-mediated dilation (FMD) occurs in disease states associated with atherosclerosis, including SLE. The primary hemodynamic determinant of FMD is wall shear stress, which is critically dependent on the forearm microcirculation. We explored the relationship between FMD, diastolic shear stress (DSS), and the forearm microcirculation in 32 patients with SLE and 19 controls. Methods and Results—DSS was calculated using (mean diastolic velocity×8×blood viscosity)/baseline brachial artery diameter. Doppler velocity envelopes from the first 15 seconds of reactive hyperemia were analyzed for resistive index (RI), and interrogated in the frequency domain to assess forearm microvascular hemodynamics. FMD was significantly impaired in SLE patients (median, 2.4%; range, −2.1% to 10.7% versus median 5.8%; range, 1.9% to 14%; P<0.001). DSS (dyne/cm2) was significantly reduced in SLE patients (median, 18.5; range, 3.9 to 34.0 versus median 21.8; range, 14.1 to 58.7; P=0.037). A strong correlation between FMD and DSS, rs=0.65, P=0.01 was found. Postischemic RI was not significantly different between the 2 groups; however, there were significant differences in the power-frequency spectrums of the Doppler velocity envelopes (P<0.05). Conclusions—These data suggest that in SLE, altered structure and function of the forearm microcirculation contributes to impaired FMD through a reduction in shear stress stimulus.

[1]  Garret A FitzGerald,et al.  Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. , 2005, The Journal of clinical investigation.

[2]  J. Schölmerich,et al.  Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems , 2005, Annals of the rheumatic diseases.

[3]  K. Pyke,et al.  The relationship between shear stress and flow‐mediated dilatation: implications for the assessment of endothelial function , 2005, The Journal of physiology.

[4]  B. Dijkmans,et al.  Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosus , 2005, Annals of the rheumatic diseases.

[5]  D. Bluemke,et al.  Why is flow-mediated dilation dependent on arterial size? Assessment of the shear stimulus using phase-contrast magnetic resonance imaging. , 2004, American journal of physiology. Heart and circulatory physiology.

[6]  M. Levesque,et al.  The dichotomous role of nitric oxide in the pathogenesis of accelerated atherosclerosis associated with systemic lupus erythematosus. , 2004, Current molecular medicine.

[7]  Tien Yin Wong,et al.  Retinal Arteriolar Narrowing Is Associated With 5-Year Incident Severe Hypertension: The Blue Mountains Eye Study , 2004, Hypertension.

[8]  R. Klein,et al.  Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. , 2004, Archives of internal medicine.

[9]  D. Gladman,et al.  Impaired brachial artery endothelium dependent flow mediated dilation in systemic lupus erythematosus: preliminary observations , 2004, Lupus.

[10]  J. Strain,et al.  The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus. , 2004, The Journal of rheumatology.

[11]  D. Levy,et al.  Local Shear Stress and Brachial Artery Flow–Mediated Dilation: The Framingham Heart Study , 2004, Hypertension.

[12]  I. Bruce,et al.  Systemic Lupus Erythematosus: An Independent Risk Factor for Endothelial Dysfunction in Women , 2004, Circulation.

[13]  J F Potter,et al.  Extract from : , 2009 .

[14]  R. Hughson,et al.  Flow-mediated dilation in human brachial artery after different circulatory occlusion conditions. , 2004, American journal of physiology. Heart and circulatory physiology.

[15]  J. Schwartz,et al.  Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. , 2003, The New England journal of medicine.

[16]  A. Salmaggi,et al.  Endothelium and the brain in CNS lupus , 2003, Lupus.

[17]  J. Morrow,et al.  Endothelial Dysfunction in Patients With Hypertension , 2003 .

[18]  G. D. Johnston,et al.  Functional Consequences of Endothelial Nitric Oxide Synthase Uncoupling in Congestive Cardiac Failure , 2003, Circulation.

[19]  Brian P Helmke,et al.  Spatial microstimuli in endothelial mechanosignaling. , 2003, Circulation research.

[20]  D. Armstrong,et al.  Antinucleosome antibodies in the diagnosis of systemic lupus erythematosus , 2003, Annals of the rheumatic diseases.

[21]  I. Bruce,et al.  Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. II. Predictive factors for perfusion abnormalities. , 2003, The Journal of rheumatology.

[22]  F. Ruschitzka,et al.  Selective COX-2 Inhibition Improves Endothelial Function in Coronary Artery Disease , 2003, Circulation.

[23]  V R Newey,et al.  A rapid and reproducible on line automated technique to determine endothelial function , 2002, Heart.

[24]  L. T. McGrath,et al.  Production of 8-epi prostaglandin F(2alpha) in human platelets during administration of organic nitrates. , 2002, Journal of the American College of Cardiology.

[25]  David M. Herrington,et al.  Erratum: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A report of the international brachial artery reactivity task force (Journal of American College of Cardiology (2002) 39 (257-265)) , 2002 .

[26]  V R Newey,et al.  Online artery diameter measurement in ultrasound images using artificial neural networks. , 2002, Ultrasound in medicine & biology.

[27]  F. Miranda,et al.  Brachial endothelial function is impaired in patients with systemic lupus erythematosus. , 2002, The Journal of rheumatology.

[28]  E. Benjamin,et al.  Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. , 2002, Journal of the American College of Cardiology.

[29]  S. Abramson,et al.  The role of nitric oxide in tissue destruction. , 2001, Best practice & research. Clinical rheumatology.

[30]  Joao A. C. Lima,et al.  The relationship between vascular wall shear stress and flow-mediated dilation: endothelial function assessed by phase-contrast magnetic resonance angiography. , 2001, Journal of the American College of Cardiology.

[31]  M. Abrahamowicz,et al.  Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. , 2001, Arthritis and rheumatism.

[32]  A. Pries,et al.  Microcirculation in Hypertension: A New Target for Treatment? , 2001, Circulation.

[33]  L. Schmetterer,et al.  RI in central retinal artery as assessed by CDI does not correspond to retinal vascular resistance. , 2001, American journal of physiology. Heart and circulatory physiology.

[34]  T. Münzel,et al.  Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus , 2001, Circulation research.

[35]  H. Shibuya,et al.  Thallium-201 myocardial SPET in patients with collagen disease , 2000, Nuclear medicine communications.

[36]  M. Wolin Interactions of oxidants with vascular signaling systems. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[37]  P. Ferdinandy,et al.  Cardioprotective effects of the calcineurin inhibitor FK506 and the PAF receptor antagonist and free radical scavenger, EGb 761, in isolated ischemic/reperfused rat hearts. , 2000, Journal of cardiovascular pharmacology.

[38]  L. Ghiadoni,et al.  Vascular effects of endothelin-1 in essential hypertension: relationship with cyclooxygenase-derived endothelium-dependent contracting factors and nitric oxide. , 2000, Journal of cardiovascular pharmacology.

[39]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[40]  D. Isenberg,et al.  Oxidative stress in systemic lupus erythematosus and allied conditions with vascular involvement. , 1999, Rheumatology.

[41]  J M Rubin,et al.  Relationship between the resistive index and vascular compliance and resistance. , 1999, Radiology.

[42]  L. Kuller,et al.  Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. , 1999, Arthritis and rheumatism.

[43]  J. Morrow,et al.  The Isoprostanes: Unique Bioactive Products of Lipid Peroxidation , 1997, Journal of Biomedical Science.

[44]  I. Bruce,et al.  Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: a quality improvement study. , 1998, Clinical and experimental rheumatology.

[45]  R. Busse,et al.  Pulsatile Stretch and Shear Stress: Physical Stimuli Determining the Production of Endothelium-Derived Relaxing Factors , 1998, Journal of Vascular Research.

[46]  D. Merton,et al.  Effect of distal resistance on Doppler US flow patterns. , 1998, Radiology.

[47]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[48]  D. Gladman,et al.  The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[49]  R. D'Agostino,et al.  Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. , 1997, American journal of epidemiology.

[50]  S. Thompson,et al.  Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.

[51]  I. Rosenberg,et al.  Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus , 1996, The Lancet.

[52]  S. Kano,et al.  Endothelin-1 release from cultured endothelial cells induced by sera from patients with systemic lupus erythematosus. , 1995, Annals of the rheumatic diseases.

[53]  R S Reneman,et al.  A noninvasive method to estimate wall shear rate using ultrasound. , 1995, Ultrasound in medicine & biology.

[54]  L. Magder,et al.  Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. , 1994, The American journal of medicine.

[55]  A. Koller,et al.  Endothelial regulation of wall shear stress and blood flow in skeletal muscle microcirculation. , 1991, The American journal of physiology.

[56]  M. Liang,et al.  Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. , 1989, Arthritis and rheumatism.

[57]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[58]  C. Prowse,et al.  Prevention of the platelet alpha-granule release reaction by membrane-active drugs. , 1982, Thrombosis research.

[59]  M. Urowitz,et al.  The bimodal mortality pattern of systemic lupus erythematosus. , 1976, The American journal of medicine.